Barnes D
Barnes D.J., De S., van Hensbergen P., Moravcsik E., Melo. pathways activated by Bcr-Abl. Imatinib is usually a highly effective therapy for CML by inhibiting Bcr-Abl...
Barnes D.J., De S., van Hensbergen P., Moravcsik E., Melo. pathways activated by Bcr-Abl. Imatinib is usually a highly effective therapy for CML by inhibiting Bcr-Abl...